Navigation Links
Updated Results from Phase 2 Trial Demonstrate Prolonged Hematologic Relapse-Free Survival of Micromet's Blinatumomab in Patients with Acute Lymphoblastic Leukemia
Date:6/14/2010

observed in the eight patients who received blinatumomab and then underwent a transplant. This highlights the potential for blinatumomab to provide an opportunity to arrange a transplant, and potentially to improve the outcome of the transplant by safely reducing the burden of leukemia before transplant."

"These data continue to validate our confidence in blinatumomab's potential as a promising new treatment option for patients with ALL and heighten our excitement in the pivotal trial we are on track to begin in the third quarter," said Christian Itin, Ph.D, Micromet's President and Chief Executive Officer.  

Pivotal Trial in ALL

Based on the results reported to date in ALL, Micromet plans to initiate a pivotal, non-randomized, multi-center trial intended to confirm the efficacy and safety of blinatumomab in adult patients with B precursor ALL with minimal residual disease after treatment with front-line chemotherapy. Patients will receive 15 micrograms per meter squared per day of blinatumomab for 28 days followed by two weeks off therapy over a six week treatment cycle.  The primary endpoint of the study is MRD response as assessed by PCR analysis.  The key secondary endpoint is time to hematological relapse (for non-transplanted patients).  The Company currently plans to enroll up to 130 evaluable patients at approximately 70 leading cancer centers in Europe and the U.S.

Conference Call and Webcast

Micromet management will host a conference call on Tuesday, June 15 at 8:30 AM EDT to review the data presented at EHA. To participate in the conference call, please dial 866-770-7120 (domestic) or 617-213-8065 (international) and reference the access cod
'/>"/>

SOURCE Micromet, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Dendreon Presents Updated IMPACT Results Confirming PROVENGE Improves Overall Survival in Patients With Metastatic Castrate-Resistant Prostate Cancer
2. Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology
3. Poniard Pharmaceuticals Announces Updated Positive Clinical Data from Phase 2 Trial of Picoplatin in Colorectal Cancer and New Phase 1 Cardiac Safety Trial Results
4. Newly Updated Pharmacy State Law Compendium Available
5. Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data on KRX-0401 (Perifosine) in Combination with Bortezomib (+/- Dexamethasone) at the 12th International Multiple Myeloma Meeting
6. Roxane Laboratories, Inc. Updated Launch of Calcium Acetate Capsules, 667mg
7. Sunesis Pharmaceuticals Presents Updated Clinical Data From Ongoing Phase 2 Trial of Voreloxin (Formerly SNS-595) in Ovarian Cancer Patients at the 44th ASCO Annual Meeting
8. IDM Pharma Announces Updated Data From Mifamurtide (L-MTP-PE) Compassionate Access Program
9. VIA Pharmaceuticals Announces Updated DSMB Safety Results for VIA-2291 Ongoing Phase 2 Clinical Program
10. ORTHO EVRA(R) Prescribing Information Updated
11. Kosan Presents Updated Data on Hsp90 Inhibitor, Tanespimycin, in Multiple Myeloma at Ash
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... 2014   Mast Therapeutics, Inc. (NYSE ... that Santosh Vetticaden, Chief Medical Officer and Senior ... personal reasons, in mid-September.  Edwin L. Parsley ... Pharmaceuticals, which Mast acquired earlier this year, will ... interim Chief Medical Officer.  Dr. Parsley previously was ...
(Date:8/29/2014)... 2014 Research and Markets has ... Industry Report, 2014-2017" report to their offering. ... proportion of reimbursement for medical expenses, the Chinese orthopedic ... scale presenting a CAGR of 19.2% during 2009-2013. Trauma ... segments of orthopedic instruments in China ...
(Date:8/29/2014)... , Aug. 29, 2014 Does your doctor know ... 800 doctors have recommended marijuana to the over 112,000 currently ... But the majority of the other roughly 20,300+ active physicians ... very little about it – even though a poll in ... adults say they have tried it. "With ...
Breaking Medicine Technology:Mast Therapeutics Announces Management Change 2Mast Therapeutics Announces Management Change 3Mast Therapeutics Announces Management Change 4China Orthopedic Instrument Industry Report, 2014-2017 2Medical Rules Marijuana Sales in Colorado But Most Doctors Still in the Dark 2Medical Rules Marijuana Sales in Colorado But Most Doctors Still in the Dark 3Medical Rules Marijuana Sales in Colorado But Most Doctors Still in the Dark 4
... Life Spine, a medical device company that designs, ... of spine disorders, announced that on Saturday, April 2, ... Technology Training. Over twenty surgical participants ... hands-on cadaver lab training on the safe and effective ...
... Smith & Nephew,s (NYSE: SNN ; ... System, an operative hysteroscopy device for the removal of ... milestone. The TRUCLEAR System is a first-of-its ... hysteroscope with minimally invasive tissue removal capabilities, allowing a ...
Cached Medicine Technology:Smith & Nephew's TRUCLEAR System: A Gold Standard for Removal of Intrauterine Polyps and Fibroids 2Smith & Nephew's TRUCLEAR System: A Gold Standard for Removal of Intrauterine Polyps and Fibroids 3Smith & Nephew's TRUCLEAR System: A Gold Standard for Removal of Intrauterine Polyps and Fibroids 4
(Date:8/31/2014)... 2014 This September, California Library ... Library, celebrates 30 years of changing the lives ... inception, California’s Library Literacy Services has helped nearly ... read and write. , To mark the 30th ... is launching a month-long awareness campaign titled “Together, ...
(Date:8/31/2014)... Rosa, CA (PRWEB) August 31, 2014 ... A healthcare provider specializing in menopause is ... address lifestyle expectations and relief from uncomfortable symptoms with ... same time complementary therapies offer a variety of alternative ... menopausal women. While these treatment options may fall outside ...
(Date:8/31/2014)... Drinking tea reduces non-cardiovascular mortality by 24%, reveals a ... today by Professor Nicolas Danchin from France. , Professor ... or coffee it,s probably better to drink tea. Coffee ... life. Their effects on cardiovascular (CV) health have been ... investigated the effects of coffee and tea on CV ...
(Date:8/30/2014)... August 2014: Local anaesthetic is as safe and effective ... according to results of the FRANCE 2 registry presented ... France. , Dr Chopard said: "Numerous studies have shown ... with severe symptomatic aortic stenosis who are at very ... replacement. The number of TAVI procedures in France and ...
(Date:8/30/2014)... Orlando, Florida (PRWEB) August 31, 2014 ... gait walking and how a mobility device can help in ... now available for free download from the website that contains ... medical doctor for this site. , The articles deal with ... mobility device like a walking cane can help in making ...
Breaking Medicine News(10 mins):Health News:California Library Literacy Services Celebrates 30th Anniversary 2Health News:California Library Literacy Services Celebrates 30th Anniversary 3Health News:A Look at Complementary Therapies and Alternative Medicine for National Menopause Awareness Month 2Health News:A Look at Complementary Therapies and Alternative Medicine for National Menopause Awareness Month 3Health News:A Look at Complementary Therapies and Alternative Medicine for National Menopause Awareness Month 4Health News:A Look at Complementary Therapies and Alternative Medicine for National Menopause Awareness Month 5Health News:Drinking tea reduces non-CV mortality by 24 percent 2Health News:Drinking tea reduces non-CV mortality by 24 percent 3Health News:Local anesthetic for TAVI as safe and effective as general anesthetic 2Health News:Information Articles on Gait Problems from Walking-Canes.Net 2
... woes cited in new research , , TUESDAY, March 18 (HealthDay ... bone health and post-traumatic stress disorder (PTSD), an explosion of ... gathered at a special news conference Tuesday. , The findings ... to certain illnesses than others -- and how they ...
... of only a few centers in Canada that perform living ... 1980s that expands the organ donor pool. About 80 liver ... being living-donor. , All potential liver transplant donors are assessed ... the liver and vascular and bile duct anatomy. Thanks to ...
... Includes Research From Around the World, Supports,Public Health ... service,containing thousands of scientific articles by African and ... announced the,Johns Hopkins Bloomberg School of Public Health ... service one of the largest of its kind., ...
... http://www.pharmacyfraudsettlement.com with filed documents, fraud, allegations, ... ... As front line professionals dispensing medications to,Medicaid beneficiaries pharmacists are particularly ... and report Medicaid fraud, which is noted in the site., ...
... VPN service to eight sites nationwide, - Triples network bandwidth to more ... ... solution, ROCHESTER, N.Y., March 18 Time ... and data,networking solutions for businesses, today announced a multi-year, contract,to deploy an ...
... Using fMRI scanning, researchers have found that the ... also accessed when inferring the thoughts of other people ... not the case when considering those who are different ... edition of the Proceedings of the National Academy of ...
Cached Medicine News:Health News:Genetic Medicine Making Inroads Against Disease 2Health News:Genetic Medicine Making Inroads Against Disease 3Health News:Resources Top 400,000 in Hopkins International Information Service 2Health News:CVS, America's Largest Pharmacy Chain, Pays Nearly $37 Million to Settle Federal and State Generic Drug Switching Charges 2Health News:CVS, America's Largest Pharmacy Chain, Pays Nearly $37 Million to Settle Federal and State Generic Drug Switching Charges 3Health News:CooperVision Increases Network Performance While Reducing Costs With Time Warner Telecom's IP VPN 2Health News:CooperVision Increases Network Performance While Reducing Costs With Time Warner Telecom's IP VPN 3Health News:Introspective experiences inform inferences about similar people -- but not dissimilar 2Health News:Introspective experiences inform inferences about similar people -- but not dissimilar 3
... prepare the skin for maximum adhesion of ... leave a thin film on the skin's ... a barrier for natural body oils that ... or tape and helps prevent skin irritation ...
... Triad Plus BZK ... Chloride solution and are ... Benzalkonium Chloride (BZK) may ... gentle cleansing solution is ...
BD Persist Plus protective barrier provides a one-step antimicrobial barrier with minimum of 1% chlorhexidine with Up to 7-day antimicrobial effectiveness....
... Triad Plus Sterile ... and 10% Acetone Swabsticks ... a topical antiseptic, anti-infective ... Acetone Alcohol provides an ...
Medicine Products: